Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Study Details page for NCT02227238 shows no additions or deletions to core content; the study overview, design, outcomes, and IPD sharing information remain as presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:45:45.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    1%
    Check dated 2025-10-05T08:04:14.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T03:00:41.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Localization change: 'Mexico' → 'México'; version updated from v3.0.1 to v3.0.2; 'Back to Top' removed; no changes to pricing, stock, or core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:40:19.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:22:50.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations across various countries, while also removing some previously listed locations. Notably, the revision version has been updated from v2.16.12 to v3.0.0.
    Difference
    2%
    Check dated 2025-08-30T11:59:02.000Z thumbnail image

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.